BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 4398242)

  • 1. Immunocompetent cell functions in mice infected with Friend leukemia virus.
    Bennett M; Steeves RA
    J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to Friend leukemia virus in mice: effect of immunosuppression.
    Stutman O; Dupuy JM
    J Natl Cancer Inst; 1972 Nov; 49(5):1283-93. PubMed ID: 4405498
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression by leukemia viruses. IV. Effect of Friend leukemia virus on antibody-precursors as assessed by cell transfer studies.
    Ceglowski WS; Friedman H
    J Immunol; 1970 Dec; 105(6):1406-15. PubMed ID: 4921785
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
    Bennett M
    Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukemia virus-induced immunosuppression. 8. Rapid depression of in vitro leukocyte migration after infection of mice with Friend leukemia virus.
    Friedman H; Ceglowski WS
    J Immunol; 1971 Dec; 107(6):1673-81. PubMed ID: 5000989
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematopoietic CFU in mice infected by the polycythemia-inducing Friend virus. II. Survival of lethally irradiated mice grafted with spleen or bone marrow cells from infected donors.
    Wendling F; Jullien P; Tambourin P
    Radiat Res; 1973 Jul; 55(1):177-88. PubMed ID: 4577552
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 9. Reappearance and relative importance of immunocompetent cells in the thymus, spleen and lymph nodes following lethal x-irradiation and bone marrow reconstitution in mice.
    Blomgren H; Andersson B
    J Immunol; 1971 Mar; 106(3):831-4. PubMed ID: 4926268
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative potentiating and inhibitory effects of GVH reaction on formation of antibodies against a thymus-independent polysaccharide (S3).
    Byfield P; Christie GH; Howard JG
    J Immunol; 1973 Jul; 111(1):72-84. PubMed ID: 4145923
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes.
    Playfair JH; Purves EC
    Immunology; 1971 Jul; 21(1):113-21. PubMed ID: 4934135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and cellular basis of susceptibility or resistance to Friend leukemia virus infection in mice.
    Axelrad A
    Proc Can Cancer Conf; 1969; 8():313-43. PubMed ID: 5792937
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious immunological tolerance.
    Gershon RK; Kondo K
    Immunology; 1971 Dec; 21(6):903-14. PubMed ID: 4943147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Collins JJ; Genovesi EV; Livnat D; Sanfilippo F
    Cancer Res; 1981 Jun; 41(6):2407-15. PubMed ID: 7016314
    [No Abstract]   [Full Text] [Related]  

  • 16. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM; Rimm AA; Rose WC; Saltzstein EC
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract]   [Full Text] [Related]  

  • 18. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 19. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
    Isaak DD; Price JA; Reinisch CL; Cerny J
    J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.